{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:38Z","timestamp":1792788518664,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003360","name":"Ligue Genevoise contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003360","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Dr. Dubois Ferri\u00e8re Dinu-Lipatti"},{"DOI":"10.13039\/501100004201","name":"Oncosuisse","doi-asserted-by":"publisher","award":["KPS-OCS 01812-12-2005"],"award-info":[{"award-number":["KPS-OCS 01812-12-2005"]}],"id":[{"id":"10.13039\/501100004201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004201","name":"Oncosuisse","doi-asserted-by":"publisher","award":["OCS-02260-08-2008"],"award-info":[{"award-number":["OCS-02260-08-2008"]}],"id":[{"id":"10.13039\/501100004201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A_156760"],"award-info":[{"award-number":["31003A_156760"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Junctional adhesion molecule (JAM)-C is a member of the JAM family, expressed by a variety of different cell types, including human B lymphocytes and some B-cell lymphoma subtypes\u2014in particular, mantle cell lymphoma (MCL). Treatment with anti-JAM-C pAbs reduces homing of human B cells to lymphoid organs in a NOD\/SCID mouse model. In the present study, the role of JAM-C in the engraftment of human lymphoma B cells in mice was investigated. Administration of novel anti-JAM-C mAbs reduced tumor growth of JAM-C+ MCL cells in bone marrow, spleen, liver, and lymph nodes of mice. Treatment with anti-JAM-C antibodies significantly reduced the proliferation of JAM-C-expressing lymphoma B cells. Moreover, the binding of anti-JAM-C antibodies inhibited the phosphorylation of ERK1\/2, without affecting other signaling pathways. The results identify for the first time the intracellular MAPK cascade as the JAM-C-driven signaling pathway in JAM-C+ B cells. Targeting JAM-C could constitute a new therapeutic strategy reducing lymphoma B-cell proliferation and their capacity to reach supportive lymphoid microenvironments.<\/jats:p>","DOI":"10.1189\/jlb.1hi1114-549rr","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T23:29:22Z","timestamp":1464910162000},"page":"843-853","source":"Crossref","is-referenced-by-count":14,"title":["Anti-JAM-C therapy eliminates tumor engraftment in a xenograft model of mantle cell lymphoma"],"prefix":"10.1093","volume":"100","author":[{"given":"Carmen","family":"Do\u00f1ate","sequence":"first","affiliation":[{"name":"Hematology Service, University Hospital , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Vijaya Kumar","sequence":"additional","affiliation":[{"name":"Hematology Service, University Hospital , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat A","family":"Imhof","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, University Medical Center, Geneva University , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Matthes","sequence":"additional","affiliation":[{"name":"Hematology Service, University Hospital , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"2023011710430424700_B1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"2023011710430424700_B2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/bjh.12046","article-title":"Guidelines for the investigation and management of mantle cell lymphoma","volume":"159","author":"British Committee for Standards in Haematology","year":"2012","journal-title":"Br. J. Haematol."},{"key":"2023011710430424700_B3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","article-title":"Improvement of overall survival in advanced stage mantle cell lymphoma","volume":"27","author":"Herrmann","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"2023011710430424700_B4","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.107.147694","article-title":"JAM family and related proteins in leukocyte migration (Vestweber series)","volume":"27","author":"Bradfield","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2023011710430424700_B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2096","article-title":"The role of junctional adhesion molecules in vascular inflammation","volume":"7","author":"Weber","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2023011710430424700_B6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1158\/0008-5472.CAN-12-1756","article-title":"Homing of human B cells to lymphoid organs and B-cell lymphoma engraftment are controlled by cell adhesion molecule JAM-C","volume":"73","author":"DonTate","year":"2013","journal-title":"Cancer Res."},{"key":"2023011710430424700_B7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.leu.2404689","article-title":"Junctional adhesion molecule C (JAM-C) distinguishes CD27+ germinal center B lymphocytes from non-germinal center cells and constitutes a new diagnostic tool for B-cell malignancies","volume":"21","author":"Ody","year":"2007","journal-title":"Leukemia"},{"key":"2023011710430424700_B8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ceb.2005.08.003","article-title":"Mammalian tight junctions in the regulation of epithelial differentiation and proliferation","volume":"17","author":"Matter","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"2023011710430424700_B9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm1055","article-title":"Signalling to and from tight junctions","volume":"4","author":"Matter","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2023011710430424700_B10","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1073\/pnas.232058599","article-title":"Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferation","volume":"99","author":"Kovacs","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023011710430424700_B11","doi-asserted-by":"crossref","first-page":"e24592","DOI":"10.1371\/journal.pone.0024592","article-title":"Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells","volume":"6","author":"Palazzo","year":"2011","journal-title":"PLoS One"},{"key":"2023011710430424700_B12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2004.06.028","article-title":"Single cell profiling of potentiated phospho-protein networks in cancer cells","volume":"118","author":"Irish","year":"2004","journal-title":"Cell"},{"key":"2023011710430424700_B13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjh.12073","article-title":"Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma\/chronic lymphocytic leukaemia and marginal zone lymphoma patients","volume":"159","author":"Blix","year":"2012","journal-title":"Br. J. Haematol."},{"key":"2023011710430424700_B14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/stem.1624","article-title":"Function of Jam-B\/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells","volume":"32","author":"Arcangeli","year":"2014","journal-title":"Stem Cells"},{"key":"2023011710430424700_B15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.168.4.1618","article-title":"Vascular endothelial-junctional adhesion molecule (VE-JAM)\/JAM 2 interacts with T, NK, and dendritic cells through JAM 3","volume":"168","author":"Liang","year":"2002","journal-title":"J. Immunol."},{"key":"2023011710430424700_B16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1126\/science.272.5258.60","article-title":"Lymphocyte homing and homeostasis","volume":"272","author":"Butcher","year":"1996","journal-title":"Science"},{"key":"2023011710430424700_B17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nri1222","article-title":"Homing and cellular traffic in lymph nodes","volume":"3","author":"von Andrian","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2023011710430424700_B18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2023011710430424700_B19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nri1354","article-title":"Lymphocyte trafficking across high endothelial venules: dogmas and enigmas","volume":"4","author":"Miyasaka","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"2023011710430424700_B20","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2007-05-075176","article-title":"Lymphoma dissemination: the other face of lymphocyte homing","volume":"110","author":"Pals","year":"2007","journal-title":"Blood"},{"key":"2023011710430424700_B21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood.V99.1.290","article-title":"Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines","volume":"99","author":"Charrad","year":"2002","journal-title":"Blood"},{"key":"2023011710430424700_B22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1182\/blood-2003-04-1218","article-title":"CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1","volume":"103","author":"Gadhoum","year":"2004","journal-title":"Blood"},{"key":"2023011710430424700_B23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2007.070152","article-title":"Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule","volume":"171","author":"Trzpis","year":"2007","journal-title":"Am. J. Pathol."},{"key":"2023011710430424700_B24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"key":"2023011710430424700_B25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1042\/bj3510289","article-title":"Meaningful relationships: the regulation of the Ras\/Raf\/MEK\/ERK pathway by protein interactions","volume":"351","author":"Kolch","year":"2000","journal-title":"Biochem. J."},{"key":"2023011710430424700_B26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/cyto.a.10072","article-title":"Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events","volume":"55","author":"Krutzik","year":"2003","journal-title":"Cytometry A."},{"key":"2023011710430424700_B27","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/10428194.2011.601698","article-title":"Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists","volume":"53","author":"Hu","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"2023011710430424700_B28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1756-8722-6-89","article-title":"Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma","volume":"6","author":"Somovilla-Crespo","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"2023011710430424700_B29","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2011-04-347518","article-title":"Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia","volume":"119","author":"O\u2019Callaghan","year":"2012","journal-title":"Blood"},{"key":"2023011710430424700_B30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1483","article-title":"Targeting of CD44 eradicates human acute myeloid leukemic stem cells","volume":"12","author":"Jin","year":"2006","journal-title":"Nat. Med."},{"key":"2023011710430424700_B31","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/leu.2011.76","article-title":"Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist","volume":"25","author":"Parameswaran","year":"2011","journal-title":"Leukemia"},{"key":"2023011710430424700_B32","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/blood-2008-05-158311","article-title":"Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML","volume":"113","author":"Zeng","year":"2009","journal-title":"Blood"},{"key":"2023011710430424700_B33","first-page":"321","article-title":"Preliminary results from a phase I dose escalation study to determine the maximum tolerated dose of plerixafor in combination with rituximab in patients with relapsed chronic lymphocytic leukemia","volume":"95","author":"Andritsos","year":"2010","journal-title":"Haematologica"},{"key":"2023011710430424700_B34","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2013-02-482125","article-title":"Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients","volume":"122","author":"Chang","year":"2013","journal-title":"Blood"},{"key":"2023011710430424700_B35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/08830185.2013.786711","article-title":"BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies","volume":"32","author":"Robak","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"2023011710430424700_B36","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"4 RESONATE-2 Investigators","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/5\/843\/48717731\/jlb0843.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/100\/5\/843\/48717731\/jlb0843.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T05:36:17Z","timestamp":1718602577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/100\/5\/843\/6933082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,6,2]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.1hi1114-549rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,11]]},"published":{"date-parts":[[2016,6,2]]}}}